Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

26 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Zila Articles

Burst of M&A activity in pharma during 2009 led by mega-deals from Pfizer/Wyeth and Merck & Co/S-P

4 February 2010

Pharmaceutical M&A deals in 2009

4 February 2010

Zila's 3rd-qtr fiscal 2007 loss reduced

2 July 2007

3rd qtr net losses widen at Zila

21 June 2004

Zila settles for $20M with former CRO

7 July 2003

Zila gets $20m in CRO dispute

21 April 2003

Zila reports $8.8M 4th qtr revenues

12 August 2002

Zila's 52% revenue increase; 54% cut in losses

24 June 2002

Zila gets $4M for remaining dental supply operations

24 June 2002

Zila names Douglas Burkett corporate vice president

20 May 2002

New president for Zila Pharma

20 May 1999

Zila Acquires Oxycal Labs

13 November 1997

Zila Deal

17 April 1995

WORLD NEWS IN BRIEF

17 May 1993

ZILA MARKETS ORASCAN

7 December 1992

Showing 1-15 of 15 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS